| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |